MLYS
Price
$14.54
Change
+$0.24 (+1.68%)
Updated
Jul 3 closing price
Capitalization
947.65M
37 days until earnings call
OCUL
Price
$9.62
Change
+$0.16 (+1.69%)
Updated
Jul 3 closing price
Capitalization
1.53B
37 days until earnings call
Interact to see
Advertisement

MLYS vs OCUL

Header iconMLYS vs OCUL Comparison
Open Charts MLYS vs OCULBanner chart's image
Mineralys Therapeutics
Price$14.54
Change+$0.24 (+1.68%)
Volume$349.92K
Capitalization947.65M
Ocular Therapeutix
Price$9.62
Change+$0.16 (+1.69%)
Volume$1.16M
Capitalization1.53B
MLYS vs OCUL Comparison Chart in %
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLYS vs. OCUL commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a StrongBuy and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (MLYS: $14.54 vs. OCUL: $9.62)
Brand notoriety: MLYS and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 42% vs. OCUL: 52%
Market capitalization -- MLYS: $947.65M vs. OCUL: $1.53B
MLYS [@Biotechnology] is valued at $947.65M. OCUL’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLYS and OCUL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 5 bearish.
  • OCUL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OCUL is a better buy in the short-term than MLYS.

Price Growth

MLYS (@Biotechnology) experienced а +3.86% price change this week, while OCUL (@Biotechnology) price change was +1.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MLYS is expected to report earnings on Aug 11, 2025.

OCUL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.53B) has a higher market cap than MLYS($948M). MLYS YTD gains are higher at: 18.115 vs. OCUL (12.646). OCUL has higher annual earnings (EBITDA): -176.35M vs. MLYS (-201.44M). OCUL (350M) and MLYS (343M) have equal amount of cash in the bank . OCUL has higher revenues than MLYS: OCUL (59.6M) vs MLYS (0).
MLYSOCULMLYS / OCUL
Capitalization948M1.53B62%
EBITDA-201.44M-176.35M114%
Gain YTD18.11512.646143%
P/E RatioN/AN/A-
Revenue059.6M-
Total Cash343M350M98%
Total DebtN/A76.2M-
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLYSOCUL
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 15 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGCX43.020.38
+0.89%
MFS Core Equity C
GGMMX11.340.09
+0.80%
Gabelli Global Mini Mites I
DAACX10.260.08
+0.79%
SEI Diversified Equity
RMGSX11.400.03
+0.26%
Russell Inv Multi-Asset Strat S
GLPIX37.910.04
+0.11%
Goldman Sachs MLP Energy Infras Inv

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
+1.68%
PTGX - MLYS
50%
Loosely correlated
+0.71%
BIESF - MLYS
45%
Loosely correlated
N/A
XERS - MLYS
38%
Loosely correlated
+0.42%
ACLX - MLYS
36%
Loosely correlated
+1.24%
OCUL - MLYS
35%
Loosely correlated
+1.69%
More